WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

WhiteOak Capital Pharma and Healthcare Fund-Reg (G) - Portfolio Analysis

Portfolio Overview

Asset Allocation

Equity: 91.74%Others: 8.26%

Market Cap

Mid Cap: 26.63%Large Cap: 17.90%Small Cap: 42.02%Equity: 5.19%

Number of stocks

60

Top 10 Holdings

95.57% of portfolio

Market Cap of Equity

Mid Cap
26.63%
Large Cap
17.90%
Small Cap
42.02%
Equity
5.19%

Companies Allocation of Equity

Max Healthcare Institute Ltd Ordinary Shares15.41%
Sun Pharmaceuticals Industries Ltd13.28%
Fortis Healthcare Ltd10.66%
Cipla Ltd9.56%
J.B. Chemicals & Pharmaceuticals Ltd9.17%
Laurus Labs Ltd8.88%
Divi's Laboratories Ltd8.48%
Krishna Institute of Medical Sciences Ltd7.76%
Anthem Biosciences Ltd6.51%
Apollo Hospitals Enterprise Ltd5.85%

Sector Allocation of Equity

Healthcare87.93%
Basic Materials3.23%
Financial Services0.58%

SIP Amount

Monthly SIP Date

WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.